Please assess the completion status of the following clinical trial:

Trial Title: Intratracheal Budesonide/Surfactant Prevents BPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1) birth Wt 500-1499 gm, 2) respiratory distress shortly after birth and requires resuscitation, 3) failure to NCPAP within 4 hrs after birth, defined as: a) FIO2 ≥ 0.30, pressure \> 5 cmH2O b) severe retraction c) apnea d) PCO2 ≥ 60 mmHg.~Exclusion Criteria:~* 1) lethal cardiopulmonary status, 2) severe congenital anomalies.

- Gender: ALL
- Minimum Age: 30 Minutes
- Maximum Age: 4 Hours
- Healthy Volunteers: f

Study Arms:
- Experimental (Type: ACTIVE_COMPARATOR): Curosurf + budesonide
- Placebo (Type: PLACEBO_COMPARATOR): Curosurf + saline

Based on this trial design, predict the completion outcome and termination type (if applicable).